Aducanumab and UsAgainstAlzheimer’s
Aducanumab is a proposed treatment for early Alzheimer’s disease that is intended to slow the progression of the disease. UsAgainstAlzheimer’s (UsA2) has urged the U.S. Food and Drug Administration to approve aducanumab.
Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers
The Paid Leave Alliance for Dementia Caregivers commends the Biden-Harris for making support for working families a top priority in its $1.9 trillion COVID-19 economic relief proposal but urges the administration to clarify how the proposal's paid leave expansions will cover Americans who care for older adults.
UsAgainstAlzheimer’s Commends Apple and Biogen for New Research on Monitoring Brain Health
UsAgainstAlzheimer’s commends Apple and Biogen for their investment in brain health research and working towards creating innovative technologies that would allow consumers to be more aware and in control of their brain health.
UsAgainstAlzheimer’s Applauds $300 Million Increase for Alzheimer’s Research at NIH
This $300 million increase will continue breakthrough NIH research and help our nation reach the goal of effective treatments, prevention and a cure for Alzheimer's disease. Read UsA2's statement on the 2021 Congressional spending bill and what it means for the millions of patients, caregivers and families urgently in need of breakthrough Alzheimer's innovations.
ICYMI: Capitol Hill Briefing on Preventing Alzheimer's & Dementia
The latest developing science increasingly tells us that Alzheimer’s disease and dementia may often be preventable. Tune in to this Capitol Hill briefing for policymakers, advocates, and the general public to hear Laura Gitlin, Dr. Lisa Barnes, and actress and advocate Mandy Moore speak about the possibility of prevention and the importance of lifestyle and behavior modifications to increase brain health across the lifespan.
New Report Reveals Deep Social Inequities in Counties Hard Hit by Alzheimer’s Disease Among Blacks and Latinos
Report from UsAgainstAlzheimer’s and Urban Institute highlights the importance of addressing the social determinants of health in race to cure and prevent Alzheimer's